Potassium Carbonate → 4-[(4-chloro-3-fluorophenoxy)methyl]-N-[(dimethylamino)sulfonyl]-2,5-difluorobenzamide

HRID 1525648

Reaktionsgleichung

Reaktionsgleichung von HRID 1525648
Br[CH2:2][C:3]1[C:17]([F:18])=[CH:16][C:6]([C:7]([NH:9][S:10]([N:13]([CH3:15])[CH3:14])(=[O:12])=[O:11])=[O:8])=[C:5]([F:19])[CH:4]=1.[Cl:20][C:21]1[CH:26]=[CH:25][C:24]([OH:27])=[CH:23][C:22]=1[F:28].C([O-])([O-])=O.[K+].[K+]>CS(C)=O.C(Cl)Cl.O>[Cl:20][C:21]1[CH:26]=[CH:25][C:24]([O:27][CH2:2][C:3]2[C:17]([F:18])=[CH:16][C:6]([C:7]([NH:9][S:10]([N:13]([CH3:15])[CH3:14])(=[O:12])=[O:11])=[O:8])=[C:5]([F:19])[CH:4]=2)=[CH:23][C:22]=1[F:28]

Komponenten

7

Versuchsvorschrift

To a solution of 4-(bromomethyl)-N-[(dimethylamino)sulfonyl]-2,5-difluorobenzamide (Preparation 1, 33 mg, 0.092 mmol) in DMSO (1 mL) was added 4-chloro-3-fluorophenol (13.5 mg, 0.092 mmol) and K2CO3 (25 mg, 0.18 mmol). The reaction was stirred at room temperature for 3 hours and then at 40° C. for 16 hours. After 16 hours the reaction was diluted with DCM (10 mL) and water (20 mL). The organic was separated and the aqueous was extracted with DCM (2×10 mL). The combined organics were filtered through a phase separation cartridge and reduced to dryness to give a yellow oil which was purified by reverse phase preparative HPLC to afford the title compound.

Aufarbeitung

  1. waitat 40° C. for 16 hours
  2. customThe organic was separated
  3. extractionthe aqueous was extracted with DCM (2×10 mL)
  4. filtrationThe combined organics were filtered through a phase separation cartridge
  5. customto give a yellow oil which
  6. customwas purified by reverse phase preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-a16c593e7aab4a66b786d136bd89fc33
Quelldatensatz
uspto-grants-2015_07
Patentnummer
US09085517B2

Verknüpfte Notizen

Wird geladen…